FRAGILE-COLCOVID19: A Clinical Trial Based on Early Administration of an Oral Combination of Colchicine and Prednisone in Elderly Patients with COVID-19 in Geriatric Facilities

BACKGROUND: Unprotected and fragile elderly people in nursing homes experienced the highest mortality rates during the initial coronavirus disease 2019 (COVID-19) pandemic. OBJECTIVE: Our aim was to study the role of two oral anti-inflammatory drugs, colchicine and prednisone, in elderly patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández-Rodríguez, José, Durán-Sanclemente, Julio, Prieto-González, Sergio, Araújo, Olga, Hospital-Vidal, Teresa, Casanovas, Georgina, Sapena, Víctor, Blanco, José Luis, López-Soto, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521010/
https://www.ncbi.nlm.nih.gov/pubmed/36173596
http://dx.doi.org/10.1007/s40261-022-01201-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521010/
https://www.ncbi.nlm.nih.gov/pubmed/36173596
http://dx.doi.org/10.1007/s40261-022-01201-2

Ejemplares similares